← All companiesCCorvus Pharmaceuticals, Inc.
CRVS - CIK 0001626971
Corvus Pharmaceuticals, Inc. net income by year
Corvus Pharmaceuticals, Inc. (CRVS) reported net income of -$15.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
CRVS annual net income
CRVS net income 2014-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$15.30M | +75.4% |
| FY 2024 | -$62.30M | -130.7% |
| FY 2023 | -$27.00M | +34.6% |
| FY 2022 | -$41.31M | +4.5% |
| FY 2021 | -$43.24M | -621.3% |
| FY 2020 | -$6.00M | +87.2% |
| FY 2019 | -$46.67M | +0.6% |
| FY 2018 | -$46.94M | +15.7% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Corvus Pharmaceuticals, Inc. make?
Corvus Pharmaceuticals, Inc. (CRVS) reported net income of -$15.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Corvus Pharmaceuticals, Inc.'s net income changed over time?
Between fiscal 2014 and fiscal 2025, Corvus Pharmaceuticals, Inc.'s net income declined from -$161.00K to -$15.30M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.